Skip to main content
Year archive

BioArctic — 2017 filings

All 13 regulatory filings released by BioArctic (BIOA) in 2017, sourced directly from the official regulator.

13 Filings
2017 Period
2017 filings (13)
Filing Released Lang
BioArctic announces that the Phase 2b study of BAN2401 in early Alzheimer´s Disease continues toward 18 month endpoint
Regulatory Filings
2017-12-21 English
BioArctic meddelar att Fas 2b studien med BAN2401 i patienter med tidig Alzheimers sjukdom fortsätter mot final analys vid 18 månader
Regulatory Filings
2017-12-21 Swedish
BioArctic presents Nomination Committee and publishes financial calendar 2018
Report Publication Announcement
2017-11-09 English
BioArctic presenterar valberedning och offentliggör finansiell kalender 2018
Governance Information
2017-11-09 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-08 Swedish
Interim / Quarterly Report 2017
Interim / Quarterly Report 9M 2017
2017-11-08 English
UTNYTTJANDE AV ÖVERTILLDELNINGSOPTION OCH AVSLUTANDE AV STABILISERINGSPERIOD
Share Issue/Capital Change
2017-11-06 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification
2017-11-01 English
Ändring av antalet aktier och röster i BioArctic AB (publ)
Declaration of Voting Results & Voting Rights Announcements
2017-10-31 Swedish
Change in the number of shares and votes in BioArctic AB (publ)
Share Issue/Capital Change
2017-10-31 English
MEDDELANDE OM STABILISERINGSÅTGÄRDER
Share Issue/Capital Change
2017-10-20 Swedish
Major Shareholding Notification 2017
Major Shareholding Notification
2017-10-17 English
ioArctics patent för bolagets produktkandidat antikroppen BAN0805 för Parkinsons sjukdom har nu beviljats i Europa
Regulatory Filings
2017-10-13 Swedish